- ►thelancet.com R Erbel, C Di Mario, J Bartunek, J Bonnier, B … - The Lancet, 2007 - Elsevier 71 stents, 10–15 mm in length and 3·0–3·5 mm in diameter, were
successfully implanted after pre-dilatation in 63 patients. Diameter stenosis
was reduced from 61·5 (SD 13·1%) to 12·6 (5·6%) with an acute gain of ... Cited by 83 - Related articles - All 24 versions
- ►onlinejacc.org DP Taggart, S Kaul, WE Boden, TB Ferguson … - Journal of the American College of Cardiology, 2008 - Am Coll Cardio Found For coronary artery disease with unprotected left main stem (LMS) stenosis,
coronary artery bypass grafting (CABG) is traditionally regarded as the
"standard of care" because of its well-documented and durable survival ... Cited by 38 - Related articles - All 25 versions
- ►ahajournals.org P Keul, M Tolle, S Lucke, K von Wnuck … - Arteriosclerosis, thrombosis, and vascular biology, 2007 - Am Heart Assoc Methods and Results— FTY720 dramatically reduced atherosclerotic lesion volume
(62.5%), macrophage (41.8%), and collagen content (63.5%) after 20 weeks of
high-cholesterol diet. In isolated aortic segments and cultured vascular ... Cited by 35 - Related articles - All 11 versions
- ►onlinejacc.org S Kaul, PK Shah, GA Diamond - Journal of the American College of Cardiology, 2007 - Elsevier Drug-eluting stents (DES) have dramatically transformed the landscape of
interventional cardiology largely on the basis of empirical evidence showing
profound reduction in angiographic and clinical restenosis without any ... Cited by 31 - Related articles - BL Direct - All 17 versions
TF Boyden, BK Nallamothu, M Moscucci, PS … - The American Journal of Cardiology, 2007 - Elsevier Diabetes mellitus is a major risk factor for restenosis in patients undergoing
percutaneous coronary intervention. Randomized controlled trials comparing
drug-eluting stents (DESs) with bare metal stents (BMSs) showed a marked ... Cited by 29 - Related articles - All 13 versions
WS Weintraub - The American Journal of Cardiology, 2007 - Elsevier The introduction of percutaneous transluminal coronary angioplasty (PTCA)
revolutionized the surgical treatment of coronary artery disease. However,
despite increased surgical experience and technical breakthroughs, ... Cited by 27 - Related articles - All 10 versions
AA Bavry, DL Bhatt - The Lancet, 2008 - Elsevier Restenosis is a serious occurrence that can lead not only to recurrent angina
and repeat revascularisation but also to acute coronary syndromes. Drug-eluting
stents revolutionised interventional cardiology owing to their pronounced ... Cited by 26 - Related articles - All 19 versions
RJ Applegate, MT Sacrinty, MA Kutcher, TT … - The American journal of cardiology, 2007 - Elsevier In clinical trials of highly selected patients, drug-eluting stents (DESs)
decreased restenosis but not the rate of acute myocardial infarction (AMI) or
death. Whether DES use has an affect on the rate of AMI or death in ... Cited by 20 - Related articles - All 9 versions
- ►onlinejacc.org GA Diamond, S Kaul - Journal of the American College of Cardiology, 2007 - Elsevier The COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug
Evaluation) trial showed that coronary interventional procedures added little to
optimal medical therapy with respect to the long-term outcome of patients ... Cited by 12 - Related articles - BL Direct - All 18 versions
- ►snupharm.ac.kr [PDF] YK Lee, J Hyung Park, H Tae Moon, D Yun … - Biomaterials, 2007 - Elsevier Although drug-eluting stents (DESs) have become the most effective means of
treating coronary artery disease, safety concerns regarding their
thrombogenicities remain to be surmounted. Here, we report on a novel type ... Cited by 11 - Related articles - All 6 versions
